Skip to main content

JHOP - March 2024 Vol 14 Special Feature

DOWNLOAD EDITORIAL PDF

Download Hopa Abstracts PDF

Editorial
HOPA Abstracts
Editorial
Editorial
New Year, New HOP(A): Return of the Annual Conference Research Abstracts
Sara S. Kim, BS, PharmD, BCOP; Adam J. DiPippo, PharmD, BCOP
Read More
HOPA Abstracts
HOPA Abstracts
Biodistribution and Shedding Analysis Following RP1 Oncolytic Immunotherapy Dosing in Patients From the IGNYTE Clinical Trial: Implications for Oncology Pharmacists
Abstract #CR02
Christina Davis, PharmD, BCOP; Praveen K. Bommareddy, PhD, BPharm, MS; Alina Monteagudo, PhD; Mohammed M. Milhem, MD; Joseph J. Sacco, MD; Tawnya Lynn Bowles, MD, et al.
Read More
HOPA Abstracts
Assessing Student Pharmacists’ Knowledge and Perceptions of Financial Toxicity Concepts Introduced in an Oncology Pharmacotherapy Course
Abstract #CR01
Charles Wight, PharmD; Matthew DellaVecchia, PhD; Nicholas Chow, PharmD, BCOP; Monica Tadros, PharmD, BCPS, BCOP
Read More
HOPA Abstracts
Characterizing Second-Line and Beyond Treatments for Primary Central Nervous System Lymphomas
Abstract #CR03
Erin K. Yeung, PharmD, BCPS, BCOP; Brian Primeaux, PharmD, BCOP; Chelsea Luo, PharmD, BCOP; Caitlin Linger, PharmD, BCOP; Sheree Chen, PharmD, BCOP; Bryan Do, PharmD, BCOP
Read More
HOPA Abstracts
Coordinating Better Outcomes in Multiple Myeloma: An Educational Initiative to Elevate Pharmacist Leadership in Novel Antibodies and CAR-T Therapy
Abstract #CR04
Jeffrey Murray, PharmD, PVI; Carmine DeLuca; Michael Beyer, PVI; Zahra Mahmoudjafari, PharmD; R. Donald Harvey, PharmD
Read More
HOPA Abstracts
Darolutamide, Enzalutamide, and Apalutamide for Nonmetastatic Castration-Resistant Prostate Cancer Patients in the United States (DEAR): Comparative Real-World Evidence
Abstract #CR05
Kirollos Hanna, PharmD, BCPS, BCOP, FACCC; Alicia K. Morgans, MD; Neal D. Shore, MD; Nasreen Khan, PhD; Niculae Constantinovici, MD; Javeed Khan, MSc, et al.
Read More
HOPA Abstracts
Dosing, Safety, and Pharmacokinetics of Combination Therapy With Darolutamide, Androgen-Deprivation Therapy, and Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer in the ARASENS Study
Abstract #CR06
Read More
HOPA Abstracts
Evaluating Patient Hesitancy in Receiving a Second Dose of Evusheld (Tixagevimab and Cilgavimab) for COVID-19 Prevention After a Food and Drug Administration Dosing Recommendation Update
Abstract #CR07
Read More
HOPA Abstracts
First-Line Nivolumab + Ipilimumab + Chemotherapy Versus Chemotherapy Alone in Metastatic Non–Small Cell Lung Cancer: CheckMate 9LA 4-Year Clinical Update
Abstract #CR08
Read More
HOPA Abstracts
Impact of Frailty on Outcomes After CAR T-Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma
Abstract #CR09
Read More
HOPA Abstracts
Improving Post-Transplant Vaccination Compliance via Implementation of a Clinical Pharmacist–Managed Service
Abstract #CR10
Read More
HOPA Abstracts
Incidence and Outcomes of Pneumonitis/Interstitial Lung Disease in Patients Receiving Trastuzumab Deruxtecan
Abstract #CR11
Read More
HOPA Abstracts
Number-Needed-to-Treat Analyses of Zanubrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia
Abstract #CR13
Read More
HOPA Abstracts
Pharmacist-Led Monitoring for Patients Initiating PARP Inhibitor Therapy
Abstract #CR16
Read More
HOPA Abstracts
Patient Perspective: Logistics of Intravenous Iron Administration and Adherence to Therapy
Abstract #CR15
Read More
HOPA Abstracts
Predictive Factors of Dose Reduction Among Patients Treated With Palbociclib for Advanced or Metastatic Breast Cancer in a Real-World Setting
Abstract #CR17
Read More
HOPA Abstracts, PARP Inhibitors
Real-Life Study: Evaluation of the Safety of PARP Inhibitors in Ovarian Cancer at the Centre Hospitalier de l’Université de Montréal (CHUM)
Abstract #CR18
Read More
HOPA Abstracts
Remote Outpatient Temperature Monitoring for Early Detection of Febrile Neutropenia After High-Dose Cytarabine Consolidation Chemotherapy (the REMEDY Trial)
Abstract #CR19
Read More
HOPA Abstracts
Survey of PGY-2 Oncology Residency Program Directors to Assess Current Resources and Effects on Burnout
Abstract #CR20
Read More
HOPA Abstracts
Taxane Titration: To Prime or Not to Prime?
Abstract #CR21
Read More
HOPA Abstracts
Treatment and Outcomes Associated With Caplacizumab in the Management of Acquired Thrombotic Thrombocytopenic Purpura
Abstract #CR22
Read More
HOPA Abstracts
Pharmacist Interventions Resulting From a Health System Specialty Pharmacy 14-Day Oncology Check-In Protocol
Abstract #LB02
Read More
HOPA Abstracts
Comparison of the Efficacy of Generic Plerixafor Versus Mozobil as Adjunct Peripheral Blood Stem-Cell Mobilization Agents in Patients With Multiple Myeloma
Abstract #LB01
Read More
HOPA Abstracts, Methotrexate
Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate vs Tacrolimus and Methotrexate as GVHD Prevention Following Allogeneic Stem Cell Transplant With Myeloablative Conditioning
Abstract #LB03
Read More
HOPA Abstracts
Real-World Clinical Outcomes With Fostamatinib for the Treatment of Refractory Chronic Immune Thrombocytopenia
Abstract #LB04
Read More
HOPA Abstracts
Unlocking Geographic Disparities in Lung Cancer Incidence Calls for Tailored Interventions and Pharmacist Partnerships
Abstract #LB05
Read More